Timken Co. to Acquire Torrington from Ingersoll-Rand

It was announced today that the Timken Company had reached an agreement with Ingersoll-Rand to acquire their Torrington subsidiary. The acquisition is valued at approximately $840 million, made up of $700 million in cash and $140 million in Timken stock. The deal is expected to close in the first quarter of 2003.

Torrington are a world leader in the manufacture needle roller, heavy duty roller and ball bearings. The acquisition will make Timken the third largest bearings company in the world and enable them to offer their customers a larger product range.

The acquisition also significantly expands Timken’s range of products for the automotive and industrial bearings-based industries. In fact they will become one of the top 100 automotive suppliers worldwide, with operations in 26 countries.

For more information on bearings, click here.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    The Timken Co.. (2019, March 19). Timken Co. to Acquire Torrington from Ingersoll-Rand. AZoM. Retrieved on July 12, 2024 from https://www.azom.com/news.aspx?newsID=334.

  • MLA

    The Timken Co.. "Timken Co. to Acquire Torrington from Ingersoll-Rand". AZoM. 12 July 2024. <https://www.azom.com/news.aspx?newsID=334>.

  • Chicago

    The Timken Co.. "Timken Co. to Acquire Torrington from Ingersoll-Rand". AZoM. https://www.azom.com/news.aspx?newsID=334. (accessed July 12, 2024).

  • Harvard

    The Timken Co.. 2019. Timken Co. to Acquire Torrington from Ingersoll-Rand. AZoM, viewed 12 July 2024, https://www.azom.com/news.aspx?newsID=334.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.